BioCentury
ARTICLE | Clinical News

Protalix preclinical data

October 12, 2015 7:00 AM UTC

In an inflammatory mouse model, oral PRX-106 alleviated immune-mediated hepatitis and liver damage. Additionally, PRX-106 reduced liver necrosis and levels of interferon (IFN) gamma, alanine aminotra...